Efficacy of Surgicel Powder for prevention of hematoma after septoplasty. Randomized controlled trial.
Not Applicable
Recruiting
- Conditions
- nasal septal disease
- Registration Number
- JPRN-UMIN000049470
- Lead Sponsor
- Saitama medical university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
Anticoagulant medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence of nasal septal hematoma Postoperative pain, bleeding Stress of postoperative procedures Evaluate from 1 day to 3 months postoperatively
- Secondary Outcome Measures
Name Time Method